Table 3 Performance of models in predicting pathological complete response

From: Multimodal prediction based on ultrasound for response to neoadjuvant chemotherapy in triple negative breast cancer

 

DL model

Rad model

Clinic model

BR model

Image model

BCRP model

TC

AUC

0.88 (0.83, 0.93)

0.84 (0.78, 0.90)

0.66 (0.58, 0.74)

0.63 (0.54, 0.71)

0.90 (0.86, 0.95)

0.94 (0.91, 0.98)

Accuracy

0.83 (0.77, 0.89)

0.78 (0.71, 0.85)

0.64 (0.56, 0.72)

0.61 (0.52, 0.69)

0.83 (0.77, 0.89)

0.86 (0.81, 0.92)

Sensitivity

0.81 (0.75, 0.88)

0.76 (0.69, 0.83)

0.82 (0.76, 0.89)

0.69 (0.61, 0.77)

0.76 (0.69, 0.83)

0.80 (0.74, 0.87)

Specificity

0.84 (0.78, 0.90)

0.80 (0.74, 0.87)

0.44 (0.35, 0.52)

0.51 (0.42, 0.60)

0.90 (0.86, 0.95)

0.93 (0.89, 0.97)

PPV

0.85 (0.79, 0.91)

0.81 (0.75, 0.88)

0.62 (0.54, 0.70)

0.61 (0.52, 0.70)

0.90 (0.85, 0.94)

0.92 (0.88, 0.97)

NPV

0.80 (0.74, 0.87)

0.75 (0.68, 0.82)

0.69 (0.61, 0.77)

0.60 (0.52, 0.68)

0.77 (0.70, 0.84)

0.81 (0.74, 0.88)

ETC

AUC

0.77 (0.66, 0.87)

0.72 (0.62, 0.83)

0.55 (0.43, 0.66)

0.58 (0.46, 0.69)

0.80 (0.71, 0.90)

0.84 (0.75, 0.92)

Accuracy

0.71 (0.60, 0.82)

0.73 (0.62, 0.83)

0.51 (0.39, 0.63)

0.55 (0.43, 0.66)

0.75 (0.64, 0.85)

0.77 (0.67, 0.87)

Sensitivity

0.71 (0.61, 0.82)

0.74 (0.64, 0.85)

0.49 (0.37, 0.60)

0.60 (0.49, 0.72)

0.63 (0.51, 0.74)

0.74 (0.64, 0.85)

Specificity

0.71 (0.60, 0.82)

0.72 (0.61, 0.83)

0.52 (0.40, 0.64)

0.52 (0.40, 0.64)

0.80 (0.70, 0.90)

0.79 (0.69, 0.89)

PPV

0.53 (0.42, 0.65)

0.55 (0.44, 0.67)

0.32 (0.22, 0.42)

0.37 (0.26, 0.48)

0.59 (0.48, 0.71)

0.62 (0.50, 0.73)

NPV

0.84 (0.75, 0.93)

0.86 (0.77, 0.94)

0.68 (0.57, 0.80)

0.74 (0.63, 0.84)

0.82 (0.73, 0.91)

0.87 (0.79, 0.95)

  1. Data are presented as mean with 95% confidence interval. AUC area under the receiver operating characteristic curve, PPV positive predictive value, NPV negative predictive value.